Isabelle Ollivier-Hourmand
Overview
Explore the profile of Isabelle Ollivier-Hourmand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
2167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elkrief L, Denecheau-Girard C, Magaz M, Praktiknjo M, Colucci N, Ollivier-Hourmand I, et al.
Hepatology
. 2024 Apr;
81(1):152-167.
PMID: 38683626
Background And Aims: In patients with noncirrhotic chronic extrahepatic portal vein obstruction (EHPVO), data on the morbimortality of abdominal surgery are scarce. Approach And Results: We retrospectively analyzed the charts...
2.
Leideck P, Nkontchou G, Elkrief L, Erard D, DAlteroche L, Radenne S, et al.
Clin Res Hepatol Gastroenterol
. 2024 Apr;
48(6):102355.
PMID: 38679291
Background: Partial splenic embolization (PSE) has been proposed to treat the consequences of hypersplenism in the context of portal hypertension, especially thrombocytopenia. However, a high morbidity/mortality rate has made this...
3.
Ollivier-Hourmand I, Lebedel L, Alabau B, Goria O, Bureau C, Dumortier J, et al.
J Hepatol
. 2024 Apr;
81(3):451-460.
PMID: 38679069
Background & Aims: One-third of non-cirrhotic portal vein thrombosis (NCPVT) cases are associated with local factors. The risk of rethrombosis after anticoagulation withdrawal is unknown. We aimed to determine factors...
4.
Maan R, Lauw M, China L, Patch D, Baiges A, Garcia-Pagan J, et al.
Hepatology
. 2024 Feb;
80(5):1147-1157.
PMID: 38358465
Background And Aims: Since the introduction of SARS-CoV-2 vaccines, several cases of vaccine-induced immune thrombocytopenia and thrombosis (VITT) have been described, especially cerebral vein thrombosis. We aimed to retrospectively collect...
5.
Comoz B, Ollivier-Hourmand I, Bouvier A, Nousbaum J, Nguyen T, Launoy G, et al.
Liver Int
. 2023 Nov;
44(2):446-453.
PMID: 38010978
Background And Aims: To measure the impact of socio-economic environment on the incidence of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). Method: The study used data from the French Network...
6.
Sidali S, Borie R, Sicre de Fontbrune F, El Husseini K, Rautou P, Lainey E, et al.
Hepatology
. 2023 Nov;
79(6):1365-1380.
PMID: 37934624
Background And Aim: Germline mutations of telomere-related genes (TRG) induce multiorgan dysfunction, and liver-specific manifestations have not been clearly outlined. We aimed to describe TRG mutations-associated liver diseases. Approach And...
7.
Cadranel J, Ollivier-Hourmand I, Cadranel J, Thevenot T, Zougmore H, Nguyen-Khac E, et al.
BMC Gastroenterol
. 2023 Sep;
23(1):305.
PMID: 37697230
Background: The Hepatic hydrothorax is a pleural effusion related to portal hypertension; its diagnosis and therapeutic management may be difficult. The aims of this article are which follows: To gather...
8.
Ollivier-Hourmand I, Allaire M, Cervoni J
J Hepatol
. 2022 Feb;
77(2):566-567.
PMID: 35182660
No abstract available.
9.
Plessier A, Esposito-Farese M, Baiges A, Shukla A, Carlos Garcia Pagan J, de Raucourt E, et al.
Am J Hematol
. 2022 Jan;
97(4):431-439.
PMID: 35049058
A total of 2%-10% of patients with vascular liver disease (VLD) have paroxysmal nocturnal hemoglobinuria (PNH). Eculizumab reduces complement-mediated haemolytic activity in PNH. This study was aimed at assessing the...
10.
Ollivier-Hourmand I, Repesse Y, Nahon P, Chaffaut C, Dao T, Nguyen T, et al.
Liver Int
. 2022 Jan;
42(6):1386-1400.
PMID: 35025128
Background And Aims: Non-O blood group promotes deep vein thrombosis and liver fibrosis in both general population and hepatitis C. We aimed to evaluate the influence of Non-O group on...